标题/作者	年份
Integrated methylome and transcriptome analysis unravel the cold tolerance mechanism in winter rapeseed (Brassica napus L.) G Zheng, X Dong, J Wei, Z Liu, A Aslam, JM Cui, H Li, Y Wang, H Tian, ... BMC plant biology 22 (1), 414	2022
Immune-related lncRNA to construct novel signature and predict the immune landscape of human hepatocellular carcinoma W Hong, L Liang, Y Gu, Z Qi, H Qiu, X Yang, W Zeng, L Ma, J Xie Molecular Therapy-Nucleic Acids 22, 937-947	2020
Novel insights into the interplay between m 6 A modification and noncoding RNAs in cancer YC Yi, XY Chen, J Zhang, JS Zhu Molecular cancer 19, 1-10	2020
m6A regulator-based methylation modification patterns characterized by distinct tumor microenvironment immune profiles in colon cancer W Chong, L Shang, J Liu, Z Fang, F Du, H Wu, Y Liu, Z Wang, Y Chen, ... Theranostics 11 (5), 2201	2021
The pyroptosis-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer W Shao, Z Yang, Y Fu, L Zheng, F Liu, L Chai, J Jia Frontiers in cell and developmental biology 9, 676485	2021
Roles of RNA methylation on tumor immunity and clinical implications M Zhang, J Song, W Yuan, W Zhang, Z Sun Frontiers in immunology 12, 641507	2021
The role of N6-methyladenosine mRNA in the tumor microenvironment M Li, X Zha, S Wang Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1875 (2), 188522	2021
RNA methylations in human cancers X Han, M Wang, YL Zhao, Y Yang, YG Yang Seminars in cancer biology 75, 97-115	2021
m6A regulators is differently expressed and correlated with immune response of esophageal cancer H Zhao, Y Xu, Y Xie, L Zhang, M Gao, S Li, F Wang Frontiers in cell and developmental biology 9, 650023	2021
Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer D Zeng, J Wu, H Luo, Y Li, J Xiao, J Peng, Z Ye, R Zhou, Y Yu, G Wang, ... Journal for immunotherapy of cancer 9 (8)	2021
The evolving landscape of N6-methyladenosine modification in the tumor microenvironment Y Gu, X Wu, J Zhang, Y Fang, Y Pan, Y Shu, P Ma Molecular Therapy 29 (5), 1703-1715	2021
m6A regulator‐mediated RNA methylation modification patterns are involved in immune microenvironment regulation of periodontitis X Zhang, S Zhang, X Yan, Y Shan, L Liu, J Zhou, Q Kuang, M Li, H Long, ... Journal of cellular and molecular medicine 25 (7), 3634-3645	2021
m6A regulator-mediated methylation modification patterns and characteristics of immunity and stemness in low-grade glioma J Du, H Ji, S Ma, J Jin, S Mi, K Hou, J Dong, F Wang, C Zhang, Y Li, S Hu Briefings in bioinformatics 22 (5), bbab013	2021
Prognosis analysis and validation of m6A signature and tumor immune microenvironment in glioma S Lin, H Xu, A Zhang, Y Ni, Y Xu, T Meng, M Wang, M Lou Frontiers in Oncology 10, 541401	2020
Epigenetics: roles and therapeutic implications of non-coding RNA modifications in human cancers D Rong, G Sun, F Wu, Y Cheng, G Sun, W Jiang, X Li, Y Zhong, L Wu, ... Molecular Therapy-Nucleic Acids 25, 67-82	2021
Comprehensive analysis of PD-L1 expression, immune infiltrates, and m6A RNA methylation regulators in esophageal squamous cell carcinoma W Guo, F Tan, Q Huai, Z Wang, F Shao, G Zhang, Z Yang, R Li, Q Xue, ... Frontiers in immunology 12, 669750	2021
N6-methyladenosine RNA modification in inflammation: roles, mechanisms, and applications J Luo, T Xu, K Sun Frontiers in cell and developmental biology 9, 670711	2021
Construction and validation of an m6A RNA methylation regulators-based prognostic signature for esophageal cancer L Xu, J Pan, H Pan Cancer management and research, 5385-5394	2020
m6A modification patterns and tumor immune landscape in clear cell renal carcinoma J Zhong, Z Liu, C Cai, X Duan, T Deng, G Zeng Journal for immunotherapy of cancer 9 (2)	2021
Development and validation of an m6A RNA methylation regulator-based signature for prognostic prediction in cervical squamous cell carcinoma J Pan, L Xu, H Pan Frontiers in Oncology 10, 1444	2020

1 - 20

计算机程序会自动估算并确定日期和引用次数。